Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate

被引：0
|
作者：
Akira Sawaki
Yasuhide Yamada
Yoshito Komatsu
Tatsuo Kanda
Toshihiko Doi
Masato Koseki
Hideo Baba
Yu-Nien Sun
Koji Murakami
Toshirou Nishida
机构：
[1] Aichi Cancer Center Hospital,Department of Gastroenterology
[2] National Cancer Center Hospital,Gastrointestinal Oncology Division
[3] Hokkaido University Hospital,Department of Gastroenterology
[4] Niigata University Hospital,Digestive and General Surgery 2 Division
[5] National Cancer Center Hospital East,Division of Gastrointestinal Oncology
[6] National Hospital Organization Kure Medical Center,Department of Surgery
[7] Kumamoto University Hospital,Department of Surgical Pathology
[8] Amgen Inc.,Department of Pharmacokinetics and Drug Metabolism
[9] Dokkyo University School of Medicine,PET Center
[10] Osaka University Hospital,Department of Digestive Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词：
Motesanib; Angiogenesis inhibitor; Gastrointestinal stromal tumor (GIST);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：961 / 967
页数：6
相关论文
共 50 条
  • [1] Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
    Sawaki, Akira
    Yamada, Yasuhide
    Komatsu, Yoshito
    Kanda, Tatsuo
    Doi, Toshihiko
    Koseki, Masato
    Baba, Hideo
    Sun, Yu-Nien
    Murakami, Koji
    Nishida, Toshirou
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (05) : 961 - 967
  • [2] Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
    Shirao, Kuniaki
    Nishida, Toshirou
    Doi, Toshihiko
    Komatsu, Yoshito
    Muro, Kei
    Li, Yinhua
    Ueda, Eiji
    Ohtsu, Atsushi
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (06) : 866 - 875
  • [3] Phase I/II study of sunitinib malate in Japanese patients with gastrointestinal stromal tumor after failure of prior treatment with imatinib mesylate
    Kuniaki Shirao
    Toshirou Nishida
    Toshihiko Doi
    Yoshito Komatsu
    Kei Muro
    Yinhua Li
    Eiji Ueda
    Atsushi Ohtsu
    Investigational New Drugs, 2010, 28 : 866 - 875
  • [4] A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
    Sawaki, A
    Yamao, K
    Nakamura, T
    Suzuki, T
    Okubo, K
    Hara, K
    Kawai, H
    Yamamura, Y
    Ito, S
    Mochiduki, Y
    Ohno, R
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (04) : 329 - 333
  • [5] A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
    Akira Sawaki
    Kenji Yamao
    Tsuneya Nakamura
    Takashi Suzuki
    Kenji Okubo
    Kazuo Hara
    Hiroki Kawai
    Yoshitaka Yamamura
    Seiji Ito
    Yoshinari Mochiduki
    Ryuzo Ohno
    Journal of Gastroenterology, 2004, 39 : 329 - 333
  • [6] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
    Demetri, GD
    von Mehren, M
    Blanke, CD
    Van den Abbeele, AD
    Eisenberg, B
    Roberts, PJ
    Heinrich, MC
    Tuveson, DA
    Singer, S
    Janicek, M
    Fletcher, JA
    Silverman, SG
    Silberman, SL
    Capdeville, R
    Kiese, B
    Peng, B
    Dimitrijevic, S
    Druker, BJ
    Corless, C
    Fletcher, CDM
    Joensuu, H
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07): : 472 - 480
  • [7] Survival benefit of imatinib mesylate on patients with advanced gastrointestinal stromal tumors (GIST)
    Lin, M. T.
    Hu, T. H.
    Lin, J. W.
    Wang, C. C.
    Rau, K. M.
    Changchien, C. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A44 - A44
  • [8] Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)
    Toshirou Nishida
    Kuniaki Shirao
    Akira Sawaki
    Masato Koseki
    Takeshi Okamura
    Atsushi Ohtsu
    Toshiro Sugiyama
    Kunihisa Miyakawa
    Seiichi Hirota
    International Journal of Clinical Oncology, 2008, 13
  • [9] Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)
    Nishida, Toshirou
    Shirao, Kuniaki
    Sawaki, Akira
    Koseki, Masato
    Okamura, Takeshi
    Ohtsu, Atsushi
    Sugiyama, Toshiro
    Miyakawa, Kunihisa
    Hirota, Seiichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (03) : 244 - 251
  • [10] Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors
    Blay, J. -Y.
    Perol, D.
    Le Cesne, A.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1659 - 1665
12345